Terns Pharmaceuticals's market cap is currently $350.80M. The company's EPS TTM is $-1.178; its P/E ratio is ―; Terns Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 1.00M	$ 0.00	$ 0.00
Gross Profit	$ -881.00K	$ -1.03M	$ 488.00K	$ -394.00K	$ -195.00K
Operating Income	$ -102.56M	$ -62.03M	$ -49.86M	$ -37.02M	$ -70.20M
EBITDA	$ -102.27M	$ -58.95M	$ -49.35M	$ -36.63M	$ -35.00M
Net Income	$ -90.21M	$ -60.34M	$ -50.16M	$ -40.57M	$ -68.82M
Balance Sheet
Cash & Short-Term Investments	$ 263.44M	$ 283.11M	$ 165.98M	$ 74.85M	$ 19.65M
Total Assets	$ 268.52M	$ 287.03M	$ 168.07M	$ 92.29M	$ 23.90M
Total Debt	$ 603.00K	$ 1.21M	$ 0.00	$ 12.88M	$ 0.00
Net Debt	$ -79.32M	$ -142.03M	$ -47.70M	$ -61.97M	$ -12.33M
Total Liabilities	$ 13.15M	$ 10.08M	$ 7.77M	$ 23.70M	$ 19.70M
Stockholders' Equity	$ 255.37M	$ 276.94M	$ 160.30M	$ 68.59M	$ 4.21M
Cash Flow
Free Cash Flow	$ -67.44M	$ -49.38M	$ -42.17M	$ -30.39M	$ -67.12M
Operating Cash Flow	$ -67.39M	$ -49.11M	$ -41.83M	$ -29.81M	$ -66.22M
Investing Cash Flow	$ -37.99M	$ -22.27M	$ -119.70M	$ 6.69M	$ -3.86M
Financing Cash Flow	$ 41.95M	$ 167.50M	$ 134.39M	$ 85.52M	$ 62.00K

Currency in USD

Terns Pharmaceuticals Earnings and Revenue History

Income Statement >

Terns Pharmaceuticals Debt to Assets

Balance Sheet >

Terns Pharmaceuticals Cash Flow

Cash Flow >

Terns Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing